Skip to main content

Advertisement

SpringerLink
Log in

Preventive migraine therapy: what is new

  • KEY NOTE LECTURE
  • Published:
Neurological Sciences Aims and scope Submit manuscript

Abstract.

In this paper we review new treatment options for migraine prevention. Because we focus on new drugs, some of the data we present herein were acquired in well design double blind, controlled studies, while the efficacy of other medication is supported only by open, uncontrolled trials (noted in the text wherever appropriate).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Author information

Authors and Affiliations

  1. Department of Neurology, Columbia University College of Physicians and Surgeons, New York, NY, USA

    A. M. Rapoport

  2. Department of Neurology, Albert Einstein College of Medicine, New York, NY, USA

    M. E. Bigal

  3. The New England Center for Headache, Stamford, CT, USA

    A. M. Rapoport & M. E. Bigal

Authors
  1. A. M. Rapoport
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. E. Bigal
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rapoport, A.M., Bigal, M.E. Preventive migraine therapy: what is new. Neurol Sci 25 (Suppl 3), s177–s185 (2004). https://doi.org/10.1007/s10072-004-0281-9

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-004-0281-9

Key words

Search

Navigation